SCHEMBL24065764

SCHEMBL24065764

N#Cc1cc(C#N)cc(-c2ccc(-c3ccc(-c4nc(-c5ccc6ccccc6c5)c5ccccc5n4)c4ccccc34)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.46
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
ATM Q13315 1/20 0.40
ADORA1 P30542 1/20 0.40
CYP1A2 P05177 7/20 0.39
CYP3A4 P08684 6/20 0.39
ALDH1A1 P00352 5/20 0.39
LMNA P02545 5/20 0.39
CYP2D6 P10635 4/20 0.39
CYP2C19 P33261 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 2/20 0.39
CYP2C9 P11712 2/20 0.39
TP53 P04637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
USP2 O75604 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065781 0.93 ADORA2A (0.45) ADORA2AMEN1KMT2AATMADORA1
SCHEMBL24065800 0.91 CYP1A2 (0.44) ADORA2AMEN1KMT2AATMADORA1
SCHEMBL24065763 0.91 MEN1 (0.50) ADORA2AMEN1KMT2AATMADORA1
SCHEMBL24065770 0.91 MEN1 (0.50) ADORA2AMEN1KMT2AATMADORA1
SCHEMBL24065767 0.89 ADORA2A (0.46) ADORA2AMEN1KMT2AATMCYP1A2
SCHEMBL24065742 0.88 ABCG2 (0.47) ADORA2AMEN1KMT2AATMADORA1
SCHEMBL24065821 0.88 ADORA2A (0.48) ADORA2AMEN1KMT2AATMCYP1A2
SCHEMBL24065765 0.86 ADORA2A (0.44) ADORA2AMEN1KMT2AATMCYP1A2
SCHEMBL24065803 0.86 ADORA2A (0.44) ADORA2AMEN1KMT2AATMCYP1A2
SCHEMBL24065722 0.86 MEN1 (0.45) ADORA2AMEN1KMT2AATMADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 ADORA2A 3738/4885MEN1 780/4885KMT2A 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.